Intercept Pharmaceuticals, Inc.

STIFEL FINANCIAL CORP

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

11,264

Value ($000)

125

Weight

0.0%

2019 Q4 - 2023 Q2 (7 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	125	0.0%	11,264	6/30/2023
2022 Q2	8/15/2022	203	0.0%	14,691	6/30/2022
2022 Q1	5/13/2022	185	0.0%	11,347	3/31/2022
2020 Q4	2/12/2021	422	0.0%	17,104	12/31/2020
2020 Q3	11/16/2020	288	0.0%	6,949	9/30/2020
2020 Q2	8/14/2020	361	0.0%	7,526	6/30/2020
2019 Q4	2/13/2020	333	0.0%	2,698	12/31/2019